Initial Results of the Phase 2 Treatment Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in CLL - 100459

Spotlight
Video

Initial Results of the Phase 2 Treatment Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in CLL

moasc has 295 videos Subscribe Here

Loading........
Description: Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASC’s Spotlight On® Hematology in Huntington Beach to present "Initial Results of the Phase 2 Treatment Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in Chronic lymphocytic leukemia."
Shared By : moasc
Posted on : 02/01/18
Added : 5 months ago